Disseminated malignant melanoma and recombinant interferon: Analysis of seven consecutive phase II investigations

Journal of Investigative Dermatology

Volumn 95, Issue 6 SUPPL., 1990, Pages

  Creagan, Edward T ^a   Schaid, Daniel J ^a   Ahmann, David L ^a   Frytak, Stephen ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ANOREXIA; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT REDUCTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; DRUG EVALUATION; EFLORNITHINE; FEMALE; HUMAN; INTERFERON ALFA-2A; INTERFERON TYPE II; MALE; MELANOMA; MIDDLE AGE; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0025612122     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12875512     Document Type: Article

References (11)

1. R.J. Spiegel Clinical overview of alpha interferon: studies and future directions Cancer 59 1987 626 631
2. M.S. Roth K.A. Foon Current status of interferon therapy in oncology Prog Hematol 15 1987 19 38
3. J.R. Quesada J.U. Gutterman Interferons in the treatment of human neoplasms J Interferon Res 7 1987 575 581
4. E.T. Creagan Interferon trials in the management of malignant melanoma and other neoplasms: an overview L. Nathanson Basic and Clinical Aspects of Malignant Melanoma 1987 Martinus Nijhoff Publishers Boston
5. S.S. Legha Interferons in the treatment of malignant melanoma: a review of recent trials Cancer 57 1986 1675 1677
6. E.T. Creagan D.L. Ahmann S. Frytak H.J. Long L.M. Itri Recombinant leukocyte A interferon (rIFN-αA) in the treatment of disseminated malignant melanoma: analysis of complete and long-term responding patients Cancer 58 1986 2576 2578
7. G.J. Jones L.M. Itri Safety and tolerance of recombinant interferon alfa-2a (Roferon®-A) in cancer patients Cancer 57 1986 1709 1715
8. E.L. Kaplan P. Meier Nonparametric estimation from incomplete samples J Am Stat Assoc 53 1958 457 481
9. E.T. Creagan D.L. Ahmann H.J. Long S. Frytak S.A. Sherwin M.N. Chang Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma Cancer Treat Rep 71 1987 843 844
10. E.T. Creagan H.J. Long D.L. Ahmann D.J. Schaid Phase II assessment of recombinant leukocyte A interferon (IFN-α2A) with difluoromethylornithine (DFMO) in disseminated malignant melanoma Am J Clin Oncol 13 1990 218 220
11. E.C. Borden The expanding role of interferons Oncology Times 11 1989 5 13